BioLight Life Sciences Ltd. (TLV:BOLT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 668.60
+3.50 (0.53%)
Mar 27, 2025, 5:24 PM IDT
BioLight Life Sciences Revenue
In the year 2024, BioLight Life Sciences had annual revenue of 219.00K ILS with 85.59% growth. BioLight Life Sciences had revenue of 114.00K in the half year ending June 30, 2024, with 1,800.00% growth.
Revenue
219.00K
Revenue Growth
+85.59%
P/S Ratio
140.89
Revenue / Employee
54.75K
Employees
4
Market Cap
30.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 219.00K | 101.00K | 85.59% |
| Dec 31, 2023 | 118.00K | 55.00K | 87.30% |
| Dec 31, 2022 | 63.00K | 60.00K | 2,000.00% |
| Dec 31, 2021 | 3.00K | -28.00K | -90.32% |
| Dec 31, 2020 | 31.00K | - | - |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 60.26B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| Ilex Medical | 982.96M |
| BrainsWay | 149.39M |
| SofWave Medical | 217.27M |